Sotalol Capsule

Sotalol capsules leverage a unique pharmacological synergy by combining Class II beta-blocking properties with Class III potassium channel inhibition to effectively stabilize cardiac rhythms and manage heart rate. The capsule formulation is engineered to optimize the delivery of the active ingredient, providing a protective barrier that ensures consistent disintegration and predictable pharmacokinetic profiles for improved systemic absorption. By integrating these potent electrophysiological mechanisms within a patient-friendly delivery system, this product offers a robust clinical solution for the long-term suppression of ventricular arrhythmias and the maintenance of sinus rhythm.